This unique program is offered over 4 weeks (one full day per week) and classes can be offered on Saturdays based on the students demand. Please contact info@crownacademy.ca for more information and registration.

This postgraduate program includes the following topics:

ACMPR Quality Assurance and GPP (Good Production Practices)

Reporting of Adverse Reactions to Health Canada

ACMPR Record Keeping, Recall, and Customer Complaints Management

Selected Standard Operating Procedures (SOP) for Licensed Producers

Hygiene and Sanitation Regulations

Students can also choose the following qualification courses individually once they have completed their postgraduate certificate:

Qualification course #1: Completing an application to become a Licensed Producer in Canada

The Access to Cannabis for Medical Purposes Regulations (ACMPR) is a set of Canadian regulations enacted in July 2016 concerning the production, distribution and use of medical marijuana. (Note: in Canada the spelling "marihuana" is used instead of the United States' spelling of marijuana.) Portions of the law (MMPR) become effective on October 1, 2013, March 31, 2014 and March 31, 2015. On 24 August 2016, the law has been updated to ACMPR.

Consulting Services

We are partner for both consulting and training services. Our commitment to providing quality solutions has led Crown be recognized as a strong partner for a number of Investors, Licensed Producer Applicants and Licensed Producers.

In 2013, The MMPR program replaced the Marihuana Medical Access Regulations (MMAR). The MMAR was enacted in July 2001. Prior to a federal injunction, the MMAR program was to end on March 31, 2014. On 24 August 2016. ACMPR replaces MMPR. The MMAR program was intended to clearly define the circumstances and the manner in which access to marihuana for medical purposes would be permitted. It contained three main components: authorizations to possess dried marihuana; licences to produce marihuana, which include Personal-Use Production Licences and Designated-Person Production Licences; and access to supply of marihuana seeds or dried marihuana.

The MMPR was introduced in response to concerns from stakeholders that the MMAR was open to abuse. The MMPR treats marihuana as much as possible like any other narcotic used for medical purposes by creating conditions for a new, commercial industry that is responsible for its production and distribution. According to Health Canada, the regulations "will provide access to quality-controlled marihuana for medical purposes, produced under secure and sanitary conditions, to those Canadians who need it, while strengthening the safety of Canadian communities. In addition, the new regulations will also enable more choices of marihuana strains and licensed, commercial suppliers."

Under the MMPR, Health Canada maintains a list of authorized licensed producers of medical marihuana. While the MMPR originally only contemplated the sale of dried marijuana, recent amendments allow patients to turn their marijuana into products such as edibles and cannabis oil.

The transition from the MMAR to the MMPR and then to ACMPR program represents a substantial change in direction for the supply and acquisition of medical marihuana in Canada. It has not gone without controversy. The MMAR DPL/PPL Coalition Against Repeal is a coalition of over 6,000 members fighting for the preservation of the MMAR. An exemption was granted by a Federal Court Judge in British Columbia and permits clients who had a valid authorization to possess and/or a production license as of March 21, 2014 to continue to grow until the outcome of a Constitutional Challenge Trial that started in February 2015. In August 2016, Health Canada announced the Access to Cannabis for Medical Purposes Regulations (or ACMPR) to replace the MMPR. The new program incorporates the MMPR with a new personal cultivation regime similar to the former Marihuana Medical Access Regulations (MMAR).